Trials / Completed
CompletedNCT05591690
Use of MiniMed 780G System in Children and Adolescents
Use of MiniMed 780G System in Children and Adolescents, a French Real Life Observational Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 32 (actual)
- Sponsor
- University Hospital, Montpellier · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Hybrid closed-loop technology have shown that it improves glycemic control parameters, but the investigators do not have sufficient data at more than 6 months of follow-up, allowing us to describe the effectiveness of these systems in the long term. All MiniMed 780G system users from November 2020 to March 2022 were included (n=32) For every time points, there was a significant difference in Time In Range between the pre-AHCL and post-AHCL. Noted difference were +14.5% and, +10.8% at respectively 3 months and 1 year. No more hypoglycemia were identified. This "real-life" analysis shows that the algorithm is effective in improvement of metabolic control for T1 diabetic children and adolescents, at one year of follow-up. However, an effect of breathlessness is observed which underlined the need for a solid therapeutic education program.
Conditions
Timeline
- Start date
- 2020-11-01
- Primary completion
- 2022-06-01
- Completion
- 2022-08-31
- First posted
- 2022-10-24
- Last updated
- 2022-10-24
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05591690. Inclusion in this directory is not an endorsement.